Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

Finasteride improves urinary function in men for 2 years.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Recent advances in hair loss treatments show significant progress.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

A newly found RNA in Cashmere goats may play a role in hair growth and development.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Low TRPS1 expression in skin and hair cells is linked to hair problems in Trichorhinophalangeal syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Formulation P-08-016 better targets hair follicles for baldness treatment.

Alternative treatments show promise for hair growth beyond traditional methods.

Combination therapies work better than single treatments for hair loss.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Finasteride and minoxidil together safely and effectively increase hair growth and density for androgenetic alopecia.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.